152 related articles for article (PubMed ID: 31426965)
1. Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo.
Oliveira C; Granja S; Neves NM; Reis RL; Baltazar F; Silva TH; Martins A
Carbohydr Polym; 2019 Nov; 223():115034. PubMed ID: 31426965
[TBL] [Abstract][Full Text] [Related]
2. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities.
Koyanagi S; Tanigawa N; Nakagawa H; Soeda S; Shimeno H
Biochem Pharmacol; 2003 Jan; 65(2):173-9. PubMed ID: 12504793
[TBL] [Abstract][Full Text] [Related]
3. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J
Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187
[TBL] [Abstract][Full Text] [Related]
4. Effect of Enzymatically Extracted Fucoidans on Angiogenesis and Osteogenesis in Primary Cell Culture Systems Mimicking Bone Tissue Environment.
Ohmes J; Xiao Y; Wang F; Mikkelsen MD; Nguyen TT; Schmidt H; Seekamp A; Meyer AS; Fuchs S
Mar Drugs; 2020 Sep; 18(9):. PubMed ID: 32967359
[TBL] [Abstract][Full Text] [Related]
5. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of fucoidan in anaplastic thyroid cancer via apoptosis and anti-angiogenesis.
Shen HY; Li LZ; Xue KC; Hu DD; Gao YJ
Mol Med Rep; 2017 May; 15(5):2620-2624. PubMed ID: 28447753
[TBL] [Abstract][Full Text] [Related]
7. Influence of Fucoidan Extracts from Different Fucus Species on Adult Stem Cells and Molecular Mediators in In Vitro Models for Bone Formation and Vascularization.
Wang F; Xiao Y; Neupane S; Ptak SH; Römer R; Xiong J; Ohmes J; Seekamp A; Fretté X; Alban S; Fuchs S
Mar Drugs; 2021 Mar; 19(4):. PubMed ID: 33805470
[TBL] [Abstract][Full Text] [Related]
8. Fucoidan Derived from
Bae H; Lee JY; Yang C; Song G; Lim W
Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31936539
[TBL] [Abstract][Full Text] [Related]
9. Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo.
Xue M; Ge Y; Zhang J; Wang Q; Hou L; Liu Y; Sun L; Li Q
PLoS One; 2012; 7(8):e43483. PubMed ID: 22916270
[TBL] [Abstract][Full Text] [Related]
10. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
[TBL] [Abstract][Full Text] [Related]
11. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
Özcetin A; Aigner A; Bakowsky U
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
13. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
[TBL] [Abstract][Full Text] [Related]
15. Fucoidan extract derived from Undaria pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells.
Liu F; Wang J; Chang AK; Liu B; Yang L; Li Q; Wang P; Zou X
Phytomedicine; 2012 Jun; 19(8-9):797-803. PubMed ID: 22510492
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment.
Mathew L; Burney M; Gaikwad A; Nyshadham P; Nugent EK; Gonzalez A; Smith JA
Integr Cancer Ther; 2017 Dec; 16(4):572-584. PubMed ID: 29096568
[TBL] [Abstract][Full Text] [Related]
17. Fucoidan inhibits angiogenesis induced by multiple myeloma cells.
Liu F; Luo G; Xiao Q; Chen L; Luo X; Lv J; Chen L
Oncol Rep; 2016 Oct; 36(4):1963-72. PubMed ID: 27498597
[TBL] [Abstract][Full Text] [Related]
18. Alpha-amylase and alpha-glucosidase inhibition is differentially modulated by fucoidan obtained from Fucus vesiculosus and Ascophyllum nodosum.
Kim KT; Rioux LE; Turgeon SL
Phytochemistry; 2014 Feb; 98():27-33. PubMed ID: 24388677
[TBL] [Abstract][Full Text] [Related]
19. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
20. Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1.
Lin B; Song X; Yang D; Bai D; Yao Y; Lu N
Gene; 2018 May; 654():77-86. PubMed ID: 29454091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
